Cargando…

Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form

INTRODUCTION: A novel and simple isocratic reverse phase liquid chromatographic (RP-LC) method was developed for the quantitative determination of antioxidant-butylated hydroxy toluene (BHT) in paricalcitol hard gelatin capsule. In the paricalcitol capsule BHT concentration is very low. This method...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaghela, Bhupendrasinh, Rao, Surendra Singh, Sharma, Nitish, Balakrishna, P., Reddy, A. Malleshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658077/
https://www.ncbi.nlm.nih.gov/pubmed/23781463
http://dx.doi.org/10.4103/2229-4708.93392
_version_ 1782270222322892800
author Vaghela, Bhupendrasinh
Rao, Surendra Singh
Sharma, Nitish
Balakrishna, P.
Reddy, A. Malleshwar
author_facet Vaghela, Bhupendrasinh
Rao, Surendra Singh
Sharma, Nitish
Balakrishna, P.
Reddy, A. Malleshwar
author_sort Vaghela, Bhupendrasinh
collection PubMed
description INTRODUCTION: A novel and simple isocratic reverse phase liquid chromatographic (RP-LC) method was developed for the quantitative determination of antioxidant-butylated hydroxy toluene (BHT) in paricalcitol hard gelatin capsule. In the paricalcitol capsule BHT concentration is very low. This method is precisely able to estimate BHT at low concentration at about 0.0039 μg/mL and to separate BHT from paricalcitol main compound and other oil-based excipients. MATERIALS AND METHODS: The method was developed by using ACE-C18 (250 × 4.6 mm) 5-μm column with mobile phase containing a mixture of solvent A (water) and solvent B (methanol) in the ratio of 5:95 v/v, respectively. The flow rate was 0.8 mL/min with column temperature of 45°C and detection wavelength at 277 nm. The developed method was validated as per ICH guidelines with respect to specificity, linearity, limit of detection, limit of quantification, accuracy, precision and robustness. RESULTS: In the precision study the % RSD for the result of BHT was below 1.5% at target concentration level. The limit of detection, limit of quantification are 0.0013 μg/ mL and 0.0039 μg/mL, respectively and precision at LOQ level (0.0039 μg/mL) was with 6.2% RSD. The method was linear with concentration rage of 0.0039-0.64 μg/ mL with the correlation coefficient greater than 0.999 and % bias at 100% level are within + 2%. The percentage recoveries for BHT were calculated observed from 98.8 to 104.8%. CONCLUSION: The developed method was found to be precise, accurate, linear, selective and robust.
format Online
Article
Text
id pubmed-3658077
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36580772013-06-18 Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form Vaghela, Bhupendrasinh Rao, Surendra Singh Sharma, Nitish Balakrishna, P. Reddy, A. Malleshwar Pharm Methods Original Article INTRODUCTION: A novel and simple isocratic reverse phase liquid chromatographic (RP-LC) method was developed for the quantitative determination of antioxidant-butylated hydroxy toluene (BHT) in paricalcitol hard gelatin capsule. In the paricalcitol capsule BHT concentration is very low. This method is precisely able to estimate BHT at low concentration at about 0.0039 μg/mL and to separate BHT from paricalcitol main compound and other oil-based excipients. MATERIALS AND METHODS: The method was developed by using ACE-C18 (250 × 4.6 mm) 5-μm column with mobile phase containing a mixture of solvent A (water) and solvent B (methanol) in the ratio of 5:95 v/v, respectively. The flow rate was 0.8 mL/min with column temperature of 45°C and detection wavelength at 277 nm. The developed method was validated as per ICH guidelines with respect to specificity, linearity, limit of detection, limit of quantification, accuracy, precision and robustness. RESULTS: In the precision study the % RSD for the result of BHT was below 1.5% at target concentration level. The limit of detection, limit of quantification are 0.0013 μg/ mL and 0.0039 μg/mL, respectively and precision at LOQ level (0.0039 μg/mL) was with 6.2% RSD. The method was linear with concentration rage of 0.0039-0.64 μg/ mL with the correlation coefficient greater than 0.999 and % bias at 100% level are within + 2%. The percentage recoveries for BHT were calculated observed from 98.8 to 104.8%. CONCLUSION: The developed method was found to be precise, accurate, linear, selective and robust. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3658077/ /pubmed/23781463 http://dx.doi.org/10.4103/2229-4708.93392 Text en Copyright: © Pharmaceutical Methods http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vaghela, Bhupendrasinh
Rao, Surendra Singh
Sharma, Nitish
Balakrishna, P.
Reddy, A. Malleshwar
Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title_full Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title_fullStr Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title_full_unstemmed Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title_short Development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
title_sort development and validation of a reverse phase-liquid chromatographic method for the estimation of butylated hydroxytoluene as antioxidant in paricalcitol hard gelatin capsule formulation dosage form
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658077/
https://www.ncbi.nlm.nih.gov/pubmed/23781463
http://dx.doi.org/10.4103/2229-4708.93392
work_keys_str_mv AT vaghelabhupendrasinh developmentandvalidationofareversephaseliquidchromatographicmethodfortheestimationofbutylatedhydroxytolueneasantioxidantinparicalcitolhardgelatincapsuleformulationdosageform
AT raosurendrasingh developmentandvalidationofareversephaseliquidchromatographicmethodfortheestimationofbutylatedhydroxytolueneasantioxidantinparicalcitolhardgelatincapsuleformulationdosageform
AT sharmanitish developmentandvalidationofareversephaseliquidchromatographicmethodfortheestimationofbutylatedhydroxytolueneasantioxidantinparicalcitolhardgelatincapsuleformulationdosageform
AT balakrishnap developmentandvalidationofareversephaseliquidchromatographicmethodfortheestimationofbutylatedhydroxytolueneasantioxidantinparicalcitolhardgelatincapsuleformulationdosageform
AT reddyamalleshwar developmentandvalidationofareversephaseliquidchromatographicmethodfortheestimationofbutylatedhydroxytolueneasantioxidantinparicalcitolhardgelatincapsuleformulationdosageform